The present study was performed to investigate the effects of histamine H 1 -antagonists on the sleep-awake state in rats placed on a grid suspended over water in comparison with rats placed on sawdust. When rats were placed on the grid suspended over water, significant increases in the awake time and decreases in non-rapid eye movement (non-REM) sleep time were observed compared with in rats on sawdust, even when measured hourly for 6 h. Diphenhydramine, chlorpheniramine and promethazine caused a significant decrease in the awake time and increase in non-REM sleep time in rats placed on the grid suspended over water for 1-2 h and/or 2-3 h after administration. On the other hand, in rats placed on sawdust, no significant differences were observed in the awake time and non-REM sleep time with diphenhydramine and chlorpheniramine compared with the control. Different from these two drugs, promethazine caused a significant decrease in the awake time and increase in non-REM sleep time 1-2 h and 2-3 h after administration even when rats were placed on sawdust at a relatively high dose. These results clearly indicate that histamine H 1 -antagonists had potent effects on decreasing the awake time and increasing non-REM sleep time under the conditions of an activated histaminergic system.
In our previous study, we developed a sleep disturbance model which is useful to evaluate the hypnotic effect by placing rats on a grid suspended over water. 1) In this model, the arousal time of rats placed on the grid was higher than that of rats placed on sawdust; that is, the animals were subjected to relatively powerful stress because they were exposed to 2 stressors, a grid and water. On the other hand, it is well known that increased brain histamine turnover and release are produced by acute stress. 2, 3) In addition, Puri et al. 4) and Ray et al. 5) reported that the central histaminergic system was involved in the stress response. These findings suggest that the histaminergic system may be responsible for the high arousal level in our sleep disturbance model.
Using this model, we studied the effects of histamine H 1 -antagonists on total awake time and non-rapid eye movement (non-REM) sleep time for 6 h. 6) As a result, however, no significant difference was observed compared with control in total awake time and non-REM time, although a significant reduction was recognized in sleep latency. For these reasons, it is thought that the duration of the effect induced by diphenhydramine and chlorpheniramine was 3 or 4 h at most; therefore, in the present study, we assessed the effects of histamine H 1 -antagonists on the sleep-awake state measured hourly for 6 h using rats placed on a grid suspended over water in comparison with rats placed on sawdust.
MATERIALS AND METHODS

Animals
Male Wistar rats weighing 240-320 g (Japan SLC, Shizuoka, Japan) were used. All animals were maintained in an air-conditioned room with controlled temperature (24Ϯ2°C) and humidity (55Ϯ15%). They were housed in aluminum cages with sawdust and kept under a light-dark cycle (lights on from 07:00 to 19:00). The animals were allowed free access to food and water, except during the experiments. All procedures involving animals were conducted in accordance with the Guidelines for Animal Experiments at Okayama University Advanced Science Research Center.
Surgery The animals were anesthetized with pentobarbital sodium (Nembutal ® , 35 mg/kg, intraperitoneally (i.p.), Abbott Laboratories, North Chicago, IL, U.S.A.), and then fixed to a stereotaxic apparatus (SR-5N, Narishige, Tokyo, Japan). For electroencephalogram (EEG) recording, a stainless steel screw electrode (750 mm) was chronically fixed to the right frontal cortex (A: 0.5, L: 3.0) according to the atlas of Paxinos and Watson. 7) A stainless steel screw fixed in the left frontal bone served as a reference electrode. To record the electromyogram (EMG), stainless steel wire electrodes (200 mm) were implanted into the dorsal neck muscle. The electrodes were connected to a miniature receptacle and the whole assembly was fixed to the skull with dental cement. At least 7 d were allowed for recovery from surgery.
EEG and EMG Recordings EEG and EMG were recorded hourly with an electroencephalograph (Model EEG 4314, Nihon Kohden, Tokyo, Japan) for 6 h (10:00-16:00). The recording was carried out according to the method described previously. [8] [9] [10] The signals were amplified and filtered (EEG, 0.5-30 Hz; EMG, 16-60 Hz), and then digitized at a sampling rate of 128 Hz and recorded using the data acquisition program SleepSign ver.2.0 (Kissei Comtec, Nagano, Japan). EEG and EMG of the rat were measured in a cylindrical plastic cage (diameter, 26 cm; height, 31 cm), with its floor covered with sawdust or a stainless steel grid placed inside the plastic cage. The stainless steel rods of the grid (3 mm wide) were set 2 cm apart. The cage was filled with water up to 1 cm below the grid surface. The observation cage was placed in a sound-proof and electrically shielded box (70ϫ60ϫ60 cm).
Sleep-Awake State Analysis The sleep-awake states were automatically classified in 10-s periods as awake and non-REM sleep by SleepSign ver.2.0, according to the criteria previously described. 1, 11) As a final step, defined sleep-awake stages were examined visually and corrected, if necessary. Each state was characterized as follows: awake, lowamplitude EEG and high-voltage EMG activities and non-REM sleep, high-amplitude slow or spindle EEG and low-EMG activities. Drugs The following drugs were used: diphenhydramine hydrochloride (Sigma, St. Louis, MO, U.S.A.), chlorpheniramine maleate (Sigma, St. Louis, MO, U.S.A.) and promethazine hydrochloride (Sigma, St. Louis, MO, U.S.A.). The doses of drugs were expressed in terms of free base. All drugs were dissolved in distilled water and administered orally at 10:00, and EEG and EMG were measured hourly for 6 h after drug administration. Eight rats were used in each group, and a counterbalanced design for drug dosage was used. Drugs were administered at intervals of 7 d when the same rats were used for repeated experiments.
Data Analysis and Statistics Values are the meansϮ S.E.M. Student's t-test was used to compare the sleep-awake state in rats placed on a grid suspended over water and on sawdust. One-way analysis of variance (ANOVA) with Dunnett's test was used to estimate the drug effects.
RESULTS
Comparison of the Hourly Awake Time and Non-REM Sleep Time in Rats Placed on a Grid Suspended over
Water or Sawdust When rats were placed on a grid suspended over water, a significant increase in awake time and decrease in non-REM sleep time were observed compared with rats placed on sawdust for 6 h (Fig. 1) .
Effects of Histamine H 1 -Antagonists on Awake Time and Non-REM Sleep Time in Rats Placed on Sawdust
Both diphenhydramine and chlorpheniramine caused no significant difference in hourly awake time, even at a dose of 10 mg/kg, compared with the control. Promethazine at a dose of 10 mg/kg caused a significant decrease in awake time 1-2 h and 2-3 h after administration (Table 1) . Both diphenhydramine and chlorpheniramine also caused no significant difference compared with the control in hourly non-REM time. Promethazine showed a significant increase in non-REM sleep time at a dose of 10 mg/kg (1-2 h and 2-3 h) ( Table 2) .
Effects of Histamine H 1 -Antagonists on Awake Time and Non-REM Sleep Time in Rats Placed on a Grid Suspended over Water
In rats placed on a grid suspended over water, diphenhydramine caused a decrease in awake time (5 mg/kg, 1-2 h; 10 mg/kg, 1-2 h and 2-3 h). Chlorpheniramine and promethazine also caused a decrease in awake time (chlorpheniramine; 20 mg/kg, 1-2 h: promethazine; 5 and 10 mg/kg, 1-2 h and 2-3 h) ( Table 3 ). In non-REM sleep time, diphenhydramine at a dose of 10 mg/ kg (1-2 h and 2-3 h), chlorpheniramine at a dose of 20 mg/kg (1-2 h) and promethazine at doses of 5 and 10 mg/kg (1-2 h and 2-3 h) caused a significant increase (Table 4) .
DISCUSSION
It was confirmed that when rats were placed on a grid over water, a significant increase in awake time and decrease in non-REM sleep time were observed compared with rats placed on sawdust, even when measured hourly for 6 h. Shinomiya et al. 1) reported that the arousal time of rats placed on the grid was more remarkable than that of rats placed on sawdust because these rats were exposed to acute stress. Mazurkiewicz-Kwilecki 12) and Ito et al. 13) described that acute stress increases brain histamine turnover, and Endou et al. 14) also demonstrated that histamine release was enhanced under stressful conditions. Therefore, we studied the effects of histamine H 1 -antagonist on awake time and non-REM sleep time in rats placed on a grid suspended over water. As a result, it was found that histamine H 1 -antagonists, diphenhydramine, chlorpheniramine and promethazine, caused a significant decrease in awake time and increase in non-REM sleep time in rats placed on a grid suspended over water 1-2 h and/or 2-3 h after administration; however, in rats placed on sawdust, no significant effects were observed with diphenhydramine and chlorpheniramine on awake time and non-REM sleep time. These results indicate that histamine H 1 -antagonists are liable to have a potent effect when the central histaminergic system has been stimulated. Russo et al. 15) reported that diphenhydramine at a dose of 1 mg/kg reduced sleep latency time and the number of awakenings in pediatric sleep disorders. In contrast, Borbély and YoumbiBalderer 16) demonstrated no significant effect in sleep latency, number of awakenings and duration of awake time at night with diphenhydramine (50 mg or 70 mg) in healthy humans. These clinical findings were essentially identical to the results obtained in our present animal studies.
On the other hand, Kiyono et al. 17) and Itowi et al. 18) reported that a-fluoromethylhistidine (a-FMH), a specific inhibitor of histidine decarboxylase, decreased the awake time and increased slow wave sleep time during the dark period, whereas a-FMH showed no effect on the awake time and slow wave sleep time during the light period in rats. Mochizuki et al. 19) and Chu et al. 20) also demonstrated a clear circadian rhythm of histamine release from the anterior hypothalamus or the frontal cortex, that is, histamine release during the dark period, awake episodes, was significant higher than during the light period, sleep episodes, in rats. From these findings, it is reasonable to presume that a-FMH is more effective in the dark period, which is an arousal condition for rats than the light period. Almost the similar relationship can be expected for histamine H 1 -antagonists. The effect of promethazine on awake time and non-REM sleep was somewhat more potent than that of diphenhydramine and more potent than that of chlorpheniramine in rats placed on sawdust. The order of the potency was almost the same as that of the inhibition of the step-through active avoidance response in rats in our previous report. 21) In addition, in the same sleep disturbance model, we reported that diphenhydramine was more potent than chlorpheniramine for shortening sleep latency. Kubo et al. 22) reported that the anti-histaminergic potency of promethazine measured by the inhibition of 3 H-mepyramine binding is almost the same as that of chlorpheniramine and 5 times more potent than that of diphenhydramine. They also demonstrated that the anticholinergic potency of promethazine measured by the inhibition of 3 H-QNB binding is 12 and 14 time more potent than that of diphenhydramine and chlorpheniramine, respectively. Scopolamine, a representative anti-cholinergic drug, is well known to show a potent central depressant effect including a sleeping effect in rats. 23) It is reasonable to presume, therefore that the potent effect of promethazine to increase the awake time and decrease non-REM sleep time both in rats placed on the grid over water and on sawdust may be due to its potent anti-cholinergic in addition to anti-histaminergic effects.
In conclusion, it can be concluded that histamine H 1 -antagonists showed more potent effects to decrease the awake time and increase non-REM sleep time with an activated histaminergic system.
